Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.

作者信息

Gozzetti Alessandro, Bocchia Monica, Calabrese Simona, Pirrotta Maria Teresa, Crupi Rosaria, Raspadori Donatella, Lauria Francesco

出版信息

Acta Haematol. 2007;117(4):236-7. doi: 10.1159/000099548. Epub 2007 Feb 14.

DOI:10.1159/000099548

PMID:17308370

Abstract

摘要

相似文献

Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.

Acta Haematol. 2007;117(4):236-7. doi: 10.1159/000099548. Epub 2007 Feb 14.

Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment.

Acta Haematol. 2007;117(4):191-6. doi: 10.1159/000097920. Epub 2006 Dec 14.

Chronic phase of ETV6-ABL1 positive CML responds to imatinib.

Genes Chromosomes Cancer. 2008 Oct;47(10):919-21. doi: 10.1002/gcc.20593.

Imatinib resistant chronic myelogenous leukemia, BCR-ABL positive by chromosome and FISH analyses but negative by PCR, in a child progressing to acute basophilic leukemia: cytogenetic follow-up.

Cancer Genet Cytogenet. 2006 Oct 1;170(1):54-7. doi: 10.1016/j.cancergencyto.2005.08.026.

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts.

Leukemia. 2004 Sep;18(9):1539-40. doi: 10.1038/sj.leu.2403454.

Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature.

Leuk Res. 2009 Nov;33(11):e178-80. doi: 10.1016/j.leukres.2009.04.023. Epub 2009 May 14.

Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.

Leuk Res. 2011 Jun;35(6):e91-2. doi: 10.1016/j.leukres.2011.01.026. Epub 2011 Feb 11.

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.

Leuk Res. 2004 Apr;28(4):415-9. doi: 10.1016/j.leukres.2003.08.002.

Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.

Ann Clin Lab Sci. 2008 Summer;38(3):283-6.

Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.

Leukemia. 2005 Feb;19(2):287-9. doi: 10.1038/sj.leu.2403584.

引用本文的文献

Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic myeloid leukemia - an uncommon presentation: a case report and literature review in the post imatinib era.

Ann Hematol. 2024 Dec;103(12):6007-6013. doi: 10.1007/s00277-024-06044-9. Epub 2024 Oct 16.

Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor.

Cureus. 2020 Mar 9;12(3):e7217. doi: 10.7759/cureus.7217.

Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.

Int J Mol Sci. 2019 Dec 5;20(24):6141. doi: 10.3390/ijms20246141.

Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment.

Turk J Haematol. 2015 Jun;32(2):193-4. doi: 10.4274/tjh.2014.0211.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验